MALIGNANT SOLID TUMORS
Clinical trials for MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat cancers: dual attack with JCXH-211 and immunotherapy
Disease control Not yet recruitingThis early-stage trial tests a new drug, JCXH-211, injected directly into tumors along with an anti-PD-1 antibody given through a vein. The goal is to see if this combination is safe and tolerable for people with advanced solid tumors that have stopped responding to standard trea…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New drug SHR-4298 enters early human trials for hard-to-treat cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called SHR-4298 in 200 adults with advanced solid tumors that have spread or come back. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors or slow their growth. Participants must have good organ fu…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC